BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3871433)

  • 1. On the natural biology of the malignant cells in Hodgkin's disease.
    Olsson L
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):37-48. PubMed ID: 3871433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic attributes of the malignant cell population in Hodgkin's disease indicate a monocyte/macrophage origin.
    Olsson L; Behnke O
    Cancer Surv; 1985; 4(2):421-38. PubMed ID: 3842320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B- and T-lymphocytes in Hodgkin's disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies.
    Forni M; Hofman FM; Parker JW; Lukes RJ; Taylor CR
    Cancer; 1985 Feb; 55(4):728-37. PubMed ID: 3155642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
    Strauchen JA; Dimitriu-Bona A
    Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel.
    Abdulaziz Z; Mason DY; Stein H; Gatter KC; Nash JR
    Histopathology; 1984 Jan; 8(1):1-25. PubMed ID: 6368356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells.
    Poppema S; De Jong B; Atmosoerodjo J; Idenburg V; Visser L; De Ley L
    Cancer; 1985 Feb; 55(4):683-90. PubMed ID: 3881158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin and sternberg-reed cell antigen(s) detected by an antiserum to a cell line (L428) derived from Hodgkin's disease.
    Stein H; Gerdes J; Kirchner H; Schaadt M; Diehl V
    Int J Cancer; 1981 Oct; 28(4):425-9. PubMed ID: 6946981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
    Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
    J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathology of Hodgkin's disease.
    Strauchen JA
    Pathol Immunopathol Res; 1986; 5(3-5):253-64. PubMed ID: 3110753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hodgkin's disease--immunological aspects].
    Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
    Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
    Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease.
    Facchetti F; De Wolf-Peeters C; van den Oord JJ; Desmet VJ
    J Pathol; 1989 May; 158(1):57-65. PubMed ID: 2787853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reaction of xenogeneic and monoclonal antisera with Reed-Sternberg cells.
    Stuart AE; Jackson E; Morris CS
    J Pathol; 1982 Jun; 137(2):129-38. PubMed ID: 6979620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin.
    Pfreundschuh M; Mommertz E; Meissner M; Feller AC; Hassa R; Krueger GR; Diehl V
    Anticancer Res; 1988; 8(2):217-24. PubMed ID: 3364933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.